Company profile for CureVac

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We fight for human health – the RNA people. We are performing the pioneering research in developing a completely new class of medicine based on the molecule messenger RNA (mRNA). The principle of our technology is the use of this molecule as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. We are headquartered in Tübingen, Germany, and have sites in Frankfu...
We fight for human health – the RNA people. We are performing the pioneering research in developing a completely new class of medicine based on the molecule messenger RNA (mRNA). The principle of our technology is the use of this molecule as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. We are headquartered in Tübingen, Germany, and have sites in Frankfurt, Germany, and Boston, Massachusetts, USA. Because of our leading technology, we have received investments from SAP founder Dietmar Hopp’s dievini and from the Bill & Melinda Gates Foundation.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Paul-Ehrlich-Str. 15, 72076 Tübingen
Telephone
Telephone
+49 7071 9883 - 0
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/03/3198964/0/en/BioNTech-Achieves-Minimum-Condition-in-CureVac-Exchange-Offer.html

GLOBENEWSWIRE
03 Dec 2025

https://www.globenewswire.com/news-release/2025/11/26/3195060/0/en/BioNTech-Shares-Progress-on-Exchange-Offer-for-CureVac-Shares-and-Highlights-December-3-2025-at-9-00-a-m-Eastern-Time-Expiration.html

GLOBENEWSWIRE
26 Nov 2025

https://www.pharmiweb.com/press-release/2025-11-25/curevac-announces-voting-results-of-extraordinary-general-meeting

PHARMIWEB
25 Nov 2025

https://www.pharmiweb.com/press-release/2025-11-24/curevac-announces-financial-results-for-the-third-quarter-and-first-nine-months-of-2025-and-provides

PHARMIWEB
24 Nov 2025

https://www.globenewswire.com/news-release/2025/10/22/3170919/0/en/BioNTech-Commences-Public-Exchange-Offer-for-All-Outstanding-Shares-of-CureVac-N-V.html

GLOBENEWSWIRE
22 Oct 2025

https://www.pharmiweb.com/press-release/2025-08-15/curevac-announces-financial-results-for-the-second-quarter-and-first-half-of-2025-and-provides-busin

PHARMAWEB
15 Aug 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty